Shockwave Medical Continues to Execute on Its Growth Plans

Owning small-cap companies can be a little nerve-racking, especially if it's a medical device company that's waiting on FDA approval. For Shockwave Medical (NASDAQ: SWAV) investors, the wait is over. It received the go-ahead from the FDA for its coronary artery disease device this past month.